Latest / Stock Movers / Delta Pulls Guidance; Pharma Stocks Hit; Walmart Pushes Higher
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios podcasts, radio news, The Stock Movers podcast,
- 0:10Speaker 1: your roundup of companies making moves in the stock market,
- 0:14Speaker 1: harnessing the power of Bloomberg data.
- 0:17Speaker 2: Let's look at some stocks on the move today. We
- 0:19Speaker 2: are joined by Bloomberg's Critty Gupta on a choppy pre
- 0:23Speaker 2: market session for stocks as a whole creaty. That is
- 0:26Speaker 2: certainly what we are seeing at the micro level. For Delta,
- 0:30Speaker 2: they just reported earnings. What's the stock doing?
- 0:32Speaker 3: Good morning, Good morning, Nathan. We are getting the very
- 0:35Speaker 3: first inclination of companies starting to suspend their guidance. This
- 0:40Speaker 3: is a really big deal. I'm having a little bit
- 0:41Speaker 3: of COVID deja vous here because when you look at
- 0:44Speaker 3: some of these numbers, the earnings revisions are key to
- 0:47Speaker 3: that chart. You've seen massive numbers, massive hits to the
- 0:49Speaker 3: tech valuations. A lot of that is only if you
- 0:53Speaker 3: do indeed get those earnings revisions from these companies, or
- 0:56Speaker 3: like in COVID, you do get a suspension of the
- 1:00Speaker 3: guid of guidance there as well. So Delta DAL is
- 1:03Speaker 3: your ticker this morning, actually coming out of the gates
- 1:05Speaker 3: hire by about three percent. The market is buying this,
- 1:08Speaker 3: which is non traditional giving that they're withdrawing they're full
- 1:11Speaker 3: your guidance, calling it given current uncertainty. They're saying that
- 1:15Speaker 3: growth has largely stalled. But when you look at their
- 1:17Speaker 3: first quarter numbers, they are actually coming in line with expectation.
- 1:21Speaker 3: So the markets buying even just that is quite something
- 1:26Speaker 3: to witness because again, a very non traditional reaction for
- 1:29Speaker 3: really any company that would be suspending it's guidance. Let's
- 1:32Speaker 3: talk about some of the other weights in this market.
- 1:34Speaker 3: I think the story of the morning. Your pharma stocks
- 1:37Speaker 3: are taking the biggest beating this morning. I'm just going
- 1:39Speaker 3: to run through the laundry list of names this morning, Nathan,
- 1:41Speaker 3: if i can. Abby is top of that list.
- 1:44Speaker 1: ABBV is your.
- 1:45Speaker 3: Ticker down just shy of four percent this morning, one
- 1:48Speaker 3: hundred and sixty nine dollars to share, Abbot right on
- 1:51Speaker 3: its heels. ABT down about the same margin, trading at
- 1:54Speaker 3: one hundred and nineteen dollars a share.
- 1:56Speaker 1: There.
- 1:56Speaker 3: Then you've got Giliad Sciences as well, GILD down about
- 2:00Speaker 3: three percent. I'm seeing that their bonds are selling off
- 2:02Speaker 3: in a very big way this morning. Really keep an
- 2:05Speaker 3: eye on a on a stock simply because or some
- 2:08Speaker 3: of the kind of bonds that are trading. Credit seems
- 2:10Speaker 3: to be leading this equity market, So anything that has
- 2:12Speaker 3: a massive corporate bond hit is going to be magnified
- 2:15Speaker 3: in the equity market. You're seeing that with gilliad Sciences,
- 2:17Speaker 3: like I said, Gild down about three percent, Bristol Meyers
- 2:21Speaker 3: squib as well, Bmy down about three percent, trading at
- 2:24Speaker 3: fifty one dollars a share, and some of our favorites
- 2:27Speaker 3: there Pfizer PFE down a whopping three percent, trading at
- 2:30Speaker 3: twenty one dollars share. Nathan, I could go on and on.
- 2:33Speaker 3: The message this morning is if you are a pharmaceutical hit,
- 2:35Speaker 3: you are taking a massive hit when it comes to
- 2:39Speaker 3: your stock. And a lot of those lead actually by
- 2:41Speaker 3: some of the pain you've seen right here in Europe
- 2:43Speaker 3: as well. The likes of Nova Nordisks, for example, have
- 2:46Speaker 3: really been selling off this morning in Europe, alongside Roche
- 2:48Speaker 3: and Santa Fee as well. Nova Nordisk, I should mention
- 2:51Speaker 3: the ADRs also are available in the United States Envo
- 2:54Speaker 3: for that ticker, trading at about sixty dollars and change
- 2:58Speaker 3: down about one point two percent. I'll just mention that
- 3:00Speaker 3: about sixty percent of Nova Nordisk's revenue comes from the
- 3:04Speaker 3: United States, so this is a really great spot to
- 3:07Speaker 3: look at when you're talking about some of the movement
- 3:09Speaker 3: there in the pharmaceutical space. We're also getting some numbers
- 3:12Speaker 3: coming out of Walmart, several comments coming from the CEO
- 3:15Speaker 3: and the last twenty four hours thing that they're being
- 3:17Speaker 3: focused on keeping price as low, prices as low as
- 3:19Speaker 3: they possibly can, and really looking at some cost cutting measures.
- 3:23Speaker 3: They're reaffirming their first quarter sales guidance. In their full
- 3:27Speaker 3: year twenty twenty six guidance remains unchanged, so that's going
- 3:31Speaker 3: to be again another major one to watch, Nathan. For me,
- 3:34Speaker 3: Walmart's WMT is the tell those shares hire by two
- 3:37Speaker 3: percent this morning.
- 3:39Speaker 1: The Stock Movers podcast from Bloomberg Radio. Check back with
- 3:44Speaker 1: us throughout today for the latest roundup of companies making
- 3:47Speaker 1: news on Wall Street and for the latest market moving headlines.
- 3:51Speaker 1: Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg
- 3:55Speaker 1: dot com, and on Applecarplay and Android Auto with the
- 3:57Speaker 1: Bloomberg Business app.